2014Zhonghua xingwei yixue yu naokexue zazhiRequires access

The therapeutic effect of sertraline combined with brain function treatment for depressive episodes

Xinzi Guo, Gaifen Zhang, Qianqian Wu, Mo Sun

Open publisher page 0 citations

Abstract

Objective To observe the therapeutic effect of sertraline combined with brain function treatment instrument for depressive episodes. Methods According to sequence of hospitalization, 80 patients with depression without severe physical disease randomly divided into sertraline with brain function treatment group (40 cases, group A) and only take sertraline group (40 cases, group B), and two groups were given Sertraline 100 mg/day for 8 weeks. 24 Hamilton Depression Scale (HAMD-24) and 20 Self-rating Depression Scale (SDS-20) were assessed before and after 1, 2, 4, 6, 8 weekend treatment. Results The scores of HAMD-24 and SDS-20 were not significant difference between the two groups before treatment(P>0.05), but there were statistically significant after treatment (P<0.05). They were significantly decreased after 8 weeks treatment in group A and were decreased slightly in group B with HAMD-24 and SDS-20.Clinical efficiencies of HAMD of the two groups were 87.2 %, 76.3 %, respectively, and those of SDS were 89.7 %, 78.9 %, respectively. Clinical efficacy in group A was significantly better than that in group B (P<0.05). Conclusion Sertraline with brain function treatment instrument can shorten the onset time and improve its effect. Key words: Depression; Sertraline; Brain function treatment

About this research paper

What this paper is about

Objective To observe the therapeutic effect of sertraline combined with brain function treatment instrument for depressive episodes. Methods According to sequence of hospitalization, 80 patients with depression without severe physical disease randomly divided into sertraline with brain function treatment group (40 cases, group A) and only take sertraline group (40 cases, group B), and two groups were given Sertraline 100 mg/day for 8 weeks. 24 Hamilton Depression Scale (HAMD-24) and 20 Self-rating Depression Scale (SDS-20) were assessed before and after 1, 2, 4, 6, 8 weekend treatment. Results The scores of HAMD-24 and SDS-20 were not significant difference between the two groups before treatment(P>0.05), but there were statistically significant after treatment (P<0.05). They were significantly decreased after 8 weeks treatment in group A and were decreased slightly in group B with HAMD-24 and SDS-20.Clinical efficiencies of HAMD of the two groups were 87.2 %, 76.3 %, respectively, and those of SDS were 89.7 %, 78.9 %, respectively. Clinical efficacy in group A was significantly better than that in group B (P<0.05). Conclusion Sertraline with brain function treatment instrument can shorten the onset time and improve its effect. Key words: Depression; Sertraline; Brain function treatment

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the therapeutic effect of sertraline combined with brain function treatment instrument for depressive episodes. Methods According to sequence of hospitalization, 80 patients with depression without severe physical disease randomly divided into sertraline with brain function treatment group (40 cases, group A) and only take sertraline group (40 cases, group B), and two groups were given Sertraline 100 mg/day for 8 weeks. 24 Hamilton Depression Scale (HAMD-24) and 20 Self-rating Depression Scale (SDS-20) were assessed before and after 1, 2, 4, 6, 8 weekend treatment. Results The scores of HAMD-24 and SDS-20 were not significant difference between the two groups before treatment(P>0.05), but there were statistically significant after treatment (P<0.05). They were significantly decreased after 8 weeks treatment in group A and were decreased slightly in group B with HAMD-24 and SDS-20.Clinical efficiencies of HAMD of the two groups were 87.2 %, 76.3 %, respectively, and those of SDS were 89.7 %, 78.9 %, respectively. Clinical efficacy in group A was significantly better than that in group B (P<0.05). Conclusion Sertraline with brain function treatment instrument can shorten the onset time and improve its effect. Key words: Depression; Sertraline; Brain function treatment

Key concepts: Hamd, Sertraline, Depression (economics), Hamilton depression scale, Internal medicine, Medicine, Therapeutic effect, Rating scale

Related papers

Back to paper searchBrowse research topicsOriginal source
The therapeutic effect of sertraline combined with brain function treatment for depressive episodes — Research Paper | ScholarLens